297
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Design peptide and multi-epitope protein vaccine candidates against monkeypox virus using reverse vaccinology approach: an in-silico study

, , , , , , & ORCID Icon show all
Pages 14398-14418 | Received 10 Oct 2022, Accepted 11 Feb 2023, Published online: 08 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Abderahmane Linani, Khedidja Benarous, Ebru Erol, Leila Bou-Salah, Talia Serseg & Mohamed Yousfi. In silico analysis of identified molecules using LC–HR/MS of Cupressus sempervirens L. ethyl acetate fraction against three monkeypox virus targets. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now

Articles from other publishers (2)

S. V. Ramprasadh, Santhosh Rajakumar, S. Srinivasan, D. Susha, Sameer Sharma & Rajan Chourasiya. (2023) Computer-Aided Multi-Epitope Based Vaccine Design Against Monkeypox Virus Surface Protein A30L: An Immunoinformatics Approach. The Protein Journal 42:6, pages 645-663.
Crossref
Abhigyan Choudhury, Anshuman Chandra, Turki M. Dawoud, Hiba-Allah Nafidi, Nagendra Singh & Mohammed Bourhia. (2023) Immunoinformatics and reverse vaccinology approach in designing a novel highly immunogenic multivalent peptide-based vaccine against the human monkeypox virus. Frontiers in Molecular Biosciences 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.